世邦魏理仕:消費券計劃改善零售市道 料年內商鋪租金微升
世邦魏理仕香港顧問及交易服務商鋪資深董事溫運強表示,港府進一步公佈電子消費券計劃詳情,料720萬合資格人士可受惠,涉及金額達360億元,第一期最快8月派發,預計將在短期內對本港零售市道,尤其爲未來幾個月的暑假消費旺季帶來正面作用,對民生消費爲主的行業有幫助,例如飲食業、生活消閒類的零售商戶。
他表示,留意到不少商場及零售商在近期正積極迎接是次電子消費券的機會,連同針對已接種疫苗市民的消費優惠,相信兩者措施能進一步刺激消費,改善零售市道的氣氛,隨着本地疫情穩定受控及市道改善,預期商鋪租金在今年內都保持平穩、甚至微升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.